You are here
New Fixed Ratio Basal – Bolus Insulin Combination Therapy for Diabetes Specialists
for Diabetes Specialists
This course reviews the rationale for combining basal insulin and rapid-acting insulin analogues and highlights some important safety aspects of this treatment approach. It describes how control of fasting plasma glucose and postprandial glucose can be achieved with new fixed-ratio basal and rapid-acting insulin analogue combination. Guidance is provided that is intended to help you identify appropriate patients for these flexible and convenient combination.
The topic of this roundtable discussion is hypoglycaemia and its impact on diabetes patients. Risk factors for hypoglycaemia and potential strategies to mitigate the risk of hypoglycaemia are discussed, with a focus on new treatment options to reduce the risk of hypoglycaemia, including practical considerations and challenges to their use.
In this webcast, Professor Fonseca provides an overview of the advantages of new fixed-ratio basal–bolus insulin combination therapy and explains its indications and use in clinical practice.